Five-year findings show topical imiquimod 5% effective for low-risk BCC
Findings from a five-year trial of 5% imiquimod cream for treating superficial and nodular basal cell carcinomas show sustained benefits...
top of page
it's where dermatology lives
By John Evans, Associate Editor
Oct 21, 20162 min read
New insights into imiquimod’s mechanism of action
Recent research has uncovered aspects of the mechanism of action of imiquimod that were not previously understood, potentially revealing...
by Rob Leteste, Associate Editor
Jul 18, 20162 min read
Imiquimod 5% and 5-fluorouracil creams both efficacious, but recurrences more common with 5-fluorour
Topical creams imiquimod 5% and 5-fluorouracil both appear to be efficacious for low-risk superficial basal cell carcinoma (BCC), but...
Featured Posts
bottom of page